Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap in January 2024

World Top 100 HealthCare Products Companies List by Market Cap in January 2024, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Largest HealthCare Products Companies in 2024
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2024, World Largest HealthCare Products Companies by Market Cap in 2024.
  1. Spectrum Pharmaceuticals

    World Rank (Jan-05-2024)
    17,782
    World Rank (Jul-30-2023)
    17,782
    Market Cap (Jul-30-2023)
    0.211 Billion USD
    World Rank (Dec-25-2022)
    23,778
    Market Cap (Dec-25-2022)
    0.066 Billion USD
    World Rank (Jan-07-2022)
    19,189
    Market Cap (Jan-07-2022)
    0.19 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -161 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    Spectrum Pharmaceuticals is a Biopharmaceutical company focused on acquiring, developing and commercializing novel and targeted drug products with a primary focus in hematology and oncology. The company annual revenue is 45.8 million USD and 235 employee as on 2020. The headquarters is in USA.

  2. Adaptimmune Therapeutics

    World Rank (Jan-05-2024)
    17,897
    Market Cap (Jan-05-2024)
    0.200 Billion USD
    World Rank (Jul-30-2023)
    18,058
    Market Cap (Jul-30-2023)
    0.200 Billion USD
    World Rank (Dec-25-2022)
    17,423
    Market Cap (Dec-25-2022)
    0.223 Billion USD
    World Rank (Jan-07-2022)
    12,831
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Net Income in USD
    -186 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  3. Aldeyra Therapeutics

    World Rank (Jan-05-2024)
    17,972
    Market Cap (Jan-05-2024)
    0.197 Billion USD
    World Rank (Jul-30-2023)
    13,183
    Market Cap (Jul-30-2023)
    0.467 Billion USD
    World Rank (Dec-25-2022)
    14,120
    Market Cap (Dec-25-2022)
    0.386 Billion USD
    World Rank (Jan-07-2022)
    18,402
    Market Cap (Jan-07-2022)
    0.22 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -38 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  4. Zinzino AB (publ)

    World Rank (Jan-05-2024)
    18,008
    Market Cap (Jan-05-2024)
    0.196 Billion USD
    World Rank (Jul-30-2023)
    20,198
    Market Cap (Jul-30-2023)
    0.133 Billion USD
    World Rank (Dec-25-2022)
    22,458
    Market Cap (Dec-25-2022)
    0.086 Billion USD
    World Rank (Jan-07-2022)
    18,961
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Headquarters Country
  5. Glycomimetics

    World Rank (Jan-05-2024)
    18,034
    Market Cap (Jan-05-2024)
    0.195 Billion USD
    World Rank (Jul-30-2023)
    21,412
    Market Cap (Jul-30-2023)
    0.105 Billion USD
    World Rank (Dec-25-2022)
    20,710
    Market Cap (Dec-25-2022)
    0.119 Billion USD
    World Rank (Jan-07-2022)
    24,685
    Market Cap (Jan-07-2022)
    0.07 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Net Income in USD
    -51 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  6. Jeil Pharmaceutical

    World Rank (Jan-05-2024)
    18,097
    Market Cap (Jan-05-2024)
    0.193 Billion USD
    World Rank (Jul-30-2023)
    18,101
    Market Cap (Jul-30-2023)
    0.198 Billion USD
    World Rank (Dec-25-2022)
    16,979
    Market Cap (Dec-25-2022)
    0.243 Billion USD
    World Rank (Jan-07-2022)
    15,009
    Market Cap (Jan-07-2022)
    0.39 Billion USD
    Annual Revenue in USD
    595 Million USD
    Annual Net Income in USD
    6 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  7. Hangzhou Tianmushan Pharmaceutical Enterprise

    World Rank (Jan-05-2024)
    18,118
    Market Cap (Jan-05-2024)
    0.192 Billion USD
    World Rank (Jul-30-2023)
    19,404
    Market Cap (Jul-30-2023)
    0.155 Billion USD
    World Rank (Dec-25-2022)
    19,491
    Market Cap (Dec-25-2022)
    0.152 Billion USD
    World Rank (Jan-07-2022)
    19,714
    Market Cap (Jan-07-2022)
    0.18 Billion USD
    Headquarters Country
  8. Merrimack Pharmaceuticals

    World Rank (Jan-05-2024)
    18,132
    Market Cap (Jan-05-2024)
    0.191 Billion USD
    World Rank (Jul-30-2023)
    18,995
    Market Cap (Jul-30-2023)
    0.168 Billion USD
    World Rank (Dec-25-2022)
    19,936
    Market Cap (Dec-25-2022)
    0.139 Billion USD
    World Rank (Jan-07-2022)
    26,475
    Market Cap (Jan-07-2022)
    0.05 Billion USD
    Headquarters Country
  9. Epizyme

    World Rank (Jan-05-2024)
    18,152
    World Rank (Jul-30-2023)
    18,152
    World Rank (Dec-25-2022)
    18,152
    World Rank (Jan-07-2022)
    18,152
    Market Cap (Jan-07-2022)
    0.23 Billion USD
    Annual Revenue in USD
    16 Million USD
    Annual Net Income in USD
    -232 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Epizyme is a Treatment for Cancer and other serious diseases through novel epigenetic medicines company. The company pioneering work in epigenetic drug development is led by the advancement of tazemetostat in a number of cancer indications and treatment settings. The headquarters is in USA.
  10. Omeros Corporation

    World Rank (Jan-05-2024)
    18,164
    Market Cap (Jan-05-2024)
    0.190 Billion USD
    World Rank (Jul-30-2023)
    16,148
    Market Cap (Jul-30-2023)
    0.285 Billion USD
    World Rank (Dec-25-2022)
    19,264
    Market Cap (Dec-25-2022)
    0.159 Billion USD
    World Rank (Jan-07-2022)
    15,000
    Market Cap (Jan-07-2022)
    0.39 Billion USD
    Annual Revenue in USD
    74 Million USD
    Annual Net Income in USD
    -138 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Omeros is a Pharmaceutical Industry through novel discovery, strategic translational research and vigorous clinical programs. The company annual revenue is 13.5 million USD, total assets is 136.9 million USD and 265 employees as on 2020. The headquarters is in USA.

Share

Ads